HomePharma

Pharma

Pharma

ULTOMIRIS® (ravulizumab-cwvz) demonstrated sustained improvements in functional activities and quality of life in adults with generalized myasthenia gravis through 60 weeks

Life Sciences Times - 0
Pharma

Aizon Partners with TetraScience to Help Pharmaceutical Customers Increase the Speed and Efficiency of Drug Manufacturing

Life Sciences Times - 0
Pharma

Micreos Pharmaceuticals Welcomes Trine Ahlgreen and Carsten Edwards to Its Executive Team to Accelerate Its Next Phase of Development

Life Sciences Times - 0
Pharma

NewAmsterdam Pharma Doses First Patient in Phase 2 Trial of Obicetrapib in Combination with Ezetimibe as an Adjunct to High-Intensity Statin Therapy

Life Sciences Times - 0
Pharma

Alnylam Announces 3-Month Extension of Review Period for New Drug Application for Vutrisiran

Life Sciences Times - 0
Pharma

Blade Therapeutics Announces Feedback from FDA on End-of-Phase 1 Data Package

Life Sciences Times - 0
Pharma

ReAlta Life Sciences’ RLS-0071 Demonstrates Excellent Safety Profile and Confirmed Target Engagement in First-in-Human Phase 1 Clinical Trial

Life Sciences Times - 0
Pharma

Cenobamate (ONTOZRY®), for the Treatment of Drug-Resistant Focal-Onset Seizures in Adults, Is Now Available in the Netherlands

Life Sciences Times - 0
Pharma

FDA Clears ReAlta Life Science’s Phase 2 STAR Trial of RLS-0071 in Neonates with Hypoxic-Ischemic Encephalopathy

Life Sciences Times - 0
Pharma

Prestige Biopharma Enters MOU with Vaxine for Supply of COVID-19 Vaccine and Co-development of COVID-19/Influenza Combo Vaccine

Life Sciences Times - 0
Pharma

FDA Grants Orphan Drug Designation to Noxopharm for Sarcoma Treatment

Life Sciences Times - 0
Pharma

Mercator: Data Shows Netherlands Best Base for International Pharmaceutical Companies

Life Sciences Times - 0
1...565758...91Page 57 of 91

Most Read